Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion

Bleeding tendency increases with concomitant use of ibrutinib and anticoagulants. Our patient presented with shortness of breath and was found to have a nonmalignant hemorrhagic pericardial effusion. Ibrutinib was resumed, and percutaneous left atrial appendage occlusion was performed as a substitut...

Descripción completa

Detalles Bibliográficos
Autores principales: Jeelani, Hafiz, Sheikh, Muhammad Mubbashir, Tahir, Nayha, Ying, Grace, Prasad, Sonika, Yaremko, Maryana, Gill, Jashan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207956/
https://www.ncbi.nlm.nih.gov/pubmed/35734528
http://dx.doi.org/10.1016/j.jaccas.2022.01.027
_version_ 1784729639558578176
author Jeelani, Hafiz
Sheikh, Muhammad Mubbashir
Tahir, Nayha
Ying, Grace
Prasad, Sonika
Yaremko, Maryana
Gill, Jashan
author_facet Jeelani, Hafiz
Sheikh, Muhammad Mubbashir
Tahir, Nayha
Ying, Grace
Prasad, Sonika
Yaremko, Maryana
Gill, Jashan
author_sort Jeelani, Hafiz
collection PubMed
description Bleeding tendency increases with concomitant use of ibrutinib and anticoagulants. Our patient presented with shortness of breath and was found to have a nonmalignant hemorrhagic pericardial effusion. Ibrutinib was resumed, and percutaneous left atrial appendage occlusion was performed as a substitute for the chemical anticoagulation to decrease the drug-drug interaction. (Level of Difficulty: Intermediate.)
format Online
Article
Text
id pubmed-9207956
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-92079562022-06-21 Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion Jeelani, Hafiz Sheikh, Muhammad Mubbashir Tahir, Nayha Ying, Grace Prasad, Sonika Yaremko, Maryana Gill, Jashan JACC Case Rep Case Report Bleeding tendency increases with concomitant use of ibrutinib and anticoagulants. Our patient presented with shortness of breath and was found to have a nonmalignant hemorrhagic pericardial effusion. Ibrutinib was resumed, and percutaneous left atrial appendage occlusion was performed as a substitute for the chemical anticoagulation to decrease the drug-drug interaction. (Level of Difficulty: Intermediate.) Elsevier 2022-06-15 /pmc/articles/PMC9207956/ /pubmed/35734528 http://dx.doi.org/10.1016/j.jaccas.2022.01.027 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Jeelani, Hafiz
Sheikh, Muhammad Mubbashir
Tahir, Nayha
Ying, Grace
Prasad, Sonika
Yaremko, Maryana
Gill, Jashan
Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
title Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
title_full Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
title_fullStr Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
title_full_unstemmed Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
title_short Left Atrial Appendage Occlusion as an Alternative to Anticoagulants in Ibrutinib-Induced Hemorrhagic Pericardial Effusion
title_sort left atrial appendage occlusion as an alternative to anticoagulants in ibrutinib-induced hemorrhagic pericardial effusion
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9207956/
https://www.ncbi.nlm.nih.gov/pubmed/35734528
http://dx.doi.org/10.1016/j.jaccas.2022.01.027
work_keys_str_mv AT jeelanihafiz leftatrialappendageocclusionasanalternativetoanticoagulantsinibrutinibinducedhemorrhagicpericardialeffusion
AT sheikhmuhammadmubbashir leftatrialappendageocclusionasanalternativetoanticoagulantsinibrutinibinducedhemorrhagicpericardialeffusion
AT tahirnayha leftatrialappendageocclusionasanalternativetoanticoagulantsinibrutinibinducedhemorrhagicpericardialeffusion
AT yinggrace leftatrialappendageocclusionasanalternativetoanticoagulantsinibrutinibinducedhemorrhagicpericardialeffusion
AT prasadsonika leftatrialappendageocclusionasanalternativetoanticoagulantsinibrutinibinducedhemorrhagicpericardialeffusion
AT yaremkomaryana leftatrialappendageocclusionasanalternativetoanticoagulantsinibrutinibinducedhemorrhagicpericardialeffusion
AT gilljashan leftatrialappendageocclusionasanalternativetoanticoagulantsinibrutinibinducedhemorrhagicpericardialeffusion

Ejemplares similares